The abstract is read at the publisher; the summary is JClub's.
Reanalysis and reinterpretation of sequencing data in the Undiagnosed Diseases Network (UDN) second cohort yielded the largest share of diagnoses, with a 22.1% overall diagnostic rate (379 of 1713).
- Why it matters: Even with increasing clinical use of exome and genome sequencing, many participants remain undiagnosed, leaving a gap in effective strategies to reach diagnoses.
- What they did: The study reviewed UDN diagnostic strategies from May 24, 2017 to June 30, 2023, tracking prior and UDN ES/GS use and the contribution of case matching, clinical aggregation, and clinical testing.
- The result: Research efforts beyond standard clinical approaches were needed for 235 diagnoses (59.9%), implying that integrating research workflows with clinical expertise is central to resolving difficult cases.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.